Nitric Oxide as an Efficient Antimicrobial Treatment for Second-Degree Burn Wounds.

This article focuses on evaluating the antimicrobial efficacy of NVN4000, a nitric oxide (NO)-releasing topical formulation, in reducing microbial burden in second-degree burn wounds using a porcine model. The study demonstrated that NVN4000 at a 1.8% concentration significantly reduced biofilm-associated Methicillin-Resistant Staphylococcus aureus (MRSA USA300), Acinetobacter baumannii (AB 09-001), and Candida albicans (CA 09-024) compared to untreated wounds and silver sulfadiazine treatment. The NO delivery via NVN4000 showed superior antimicrobial activity without causing substantial tissue irritation, suggesting its potential as a novel therapy against multidrug-resistant infections in burn wounds. The findings highlight the importance of controlled NO release through polymeric macromolecules for effective biofilm disruption and microbial eradication.